The ankle-brachial index (ABI) is a simple, inexpensive diagnostic test for peripheral artery disease (PAD). However, it has shown variable accuracy for identification of significant stenosis. The authors performed a structured review of the sensitivity and specificity of ABI ≤ 0.90 for the diagnosis of PAD. MEDLINE, EMBASE, Cochrane databases, Science Citation Index database, and Biological Abstracts database were searched for studies of the sensitivity and specificity of using ABI ≤ 0.90 for the diagnosis of PAD. Eight studies comprising 2043 patients (or limbs) met the inclusion criteria. The result indicated that, although strict inclusion criteria on studies were formulated, different reference standards were found in these studies, and methods of ABI determination and characteristics of populations varied greatly. A high level of specificity (83.3-99.0%) and accuracy (72.1-89.2%) was reported for an ABI ≤ 0.90 in detecting ≥ 50% stenosis, but there were different levels of sensitivity (15-79%). Sensitivity was low, especially in elderly individuals and patients with diabetes. In conclusion, the test of ABI ≤ 0.90 can be a simple and useful tool to identify PAD with serious stenosis, and may be substituted for other non-invasive tests in clinical practice.
Introduction
Peripheral artery disease (PAD) is a clinical manifestation of the atherosclerotic process. Individuals with PAD have a three-to fourfold increased risk of cardiovascular disease (CVD) morbidity and mortality compared to individuals without PAD. Using the ankle-brachial index (ABI) ≤ 0.90, at least 6.8 million Americans (5.8%) aged 40 years or older had PAD in 2000, 1 which was different from other studies. [2] [3] [4] The age-adjusted prevalence of PAD was 12% when ABI was used to diagnose PAD in older adults. 2 An arteriography has been considered a gold standard for assessing PAD severity, location, and extent. 5 However, the general use of arteriography is limited because of the use of ionizing radiation and also because of the risk of local and systemic complications arising from the invasive nature of the procedure and the use of nephrotoxic contrast media. Consequently, several non-invasive tests have been designed for the detection of PAD in clinical practice. These tests include digital subtraction angiography (DSA), computed tomography angiography (CTA), whole body magnetic resonance angiography (WBMRA), Doppler waveform analysis (DWA), color duplex ultrasound (CDU), color duplex imaging (CDI) and ABI. Among these tests, the ABI is the most simple and inexpensive test. 6 Among well-trained technicians, its reliability has been excellent, and the validity of the test for stenosis of ≥ 50% in leg arteries is high (sensitivity ≈ 90% and specificity ≈ 98%). 7 However, different methods have existed for ABI calculation, and different cutoff values of ABI have been used in the literature. Although an ABI ≤ 0.90 has been recommended by the American Heart Association (AHA), 8 whether the higher or lower of the two ankle arterial systolic pressures should be used was not specified, and there has been some disagreement in the literature regarding the measurement of ABI. 9 The higher, the lower, or sometimes the average systolic blood pressures of the dorsal pedal and posterior tibial arteries within the legs have been used to calculate the ABI. 10 Importantly, the ABI was not compared side-by-side with results from arteriography in many studies, thus limiting accurate evaluation of the data.
The accuracy of ABI has been the primary focus of a number of studies on PAD, but to date there has been no structured review of these studies. Thus, the primary objective of the present study is to conduct a structured review to determine the accuracy of the ABI as a diagnostic tool to detect significant stenosis (≥ 50%) in PAD.
Methods

Search strategy and selection criteria
A structured review of original articles analyzing the sensitivity and specificity of ABI for the diagnosis of PAD was performed by searching MEDLINE (January 1966 to December 2008), EMBASE (January 1980 to December 2008), Web of Science -Science Citation Index database, the Cochrane Library and Biological Abstracts database (January 1969 to December 2008).
Although DSA is considered the best method for assessing PAD severity, location, and extent; 5 some studies have shown that WBMRA has good accuracy for grading stenosis with DSA as reference; [11] [12] [13] DWA was also a non-invasive method widely used to diagnose PAD; 14, 15 moreover, there was excellent agreement between arteriography and CDU findings (the coefficient of correlation was 0.95). 16 Noninvasive and easy methods of detecting PAD were preferred in clinical practice, so an imaging diagnostic technology was often used in many of the studies as a standard reference in defining serious luminal stenosis for the diagnosis of PAD. Studies were eligible if the sensitivity and specificity of ABI ≤ 0.90 for stenosis ≥ 50% in peripheral arteries were clearly reported by comparison with a standard reference such as DSA, 17, 18 WBMRA, 19 DWA, 20 CDI, 21 CDU, 16, 22 and arteriography. 23 Additionally, relevant references cited within identified publications were reviewed.
The search strategy included the following keywords in various combinations: "ankle brachial index", "ankle arm index", "peripheral arterial disease", "peripheral arterial occlusive disease", "peripheral vascular disease", "lower extremity arterial disease", "sensitivity", "specificity", and "accuracy".
The titles and abstracts of articles retrieved by this search strategy were evaluated against inclusion criteria, and the studies deemed potentially eligible were obtained by requests to authors. When overlapping or duplicate data sets were detected on the same series of patients, only the most recent or most informative study was included in the analysis.
Data extraction
Two investigators independently extracted data from selected articles, which included year of publication, first authors, patient demographics, study objective, study inclusion and exclusion criteria, reported sensitivity and specificity of ABI in PAD and summary statistics on ABI cases, if available. Studies were initially selected according to the following criteria: (i) language: English full text articles; (ii) accuracy of ABI for diagnosis of PAD: based on a reference standard; (iii) study design: cross-sectional or comparative study; and (iv) sample size: at least 50 participants.
Quality assessment
Reporting of a total of seven items was evaluated: (i) the study had a clearly stated aim; (ii) consecutive patients were included; (iii) an appropriate reference standard was used; (iv) a prospective calculation of sample size was reported; (v) a cutoff ABI value was 0.90; (vi) a threshold value of stenosis for PAD was 50%; and (vii) actual numbers of true positive, true negative, false positive and false negative results of the tests or predicted positive and negative values were reported.
Results
The initial search resulted in 256 articles. The title and abstract of each retrieved publication were reviewed to confirm that the sensitivity and specificity of ABI ≤ 0.90 for stenosis was ≥ 50% in peripheral arteries and that results were compared with a standard reference such as arteriography, DSA, CTA, WBMRA, DWA, CDI, or CDU. In the event that this information could not be determined from the abstract, the full article was retrieved and further reviewed. This process resulted in the selection of 33 studies. Of these, 25 articles were further excluded from this analysis: two used a stethoscope and an auscultatory method to determine ABI, respectively; 24, 25 one used an automatic blood pressure device to determine ABI; 26 one determined ABI at exercise; 27 two used tissue oxygen saturation and pedal pulse palpation to determine PAD, respectively; 28,29 two used ABI < 0.80 and 1.0 for PAD, respectively; 30,31 one used ABI < 0.90 for the detection of arterial lesions in extremities; 32 one used ABI > 1.3 for PAD; 33 one included patients with stenosis > 70% in leg arteries; 34 10 articles did not use an appropriate reference standard for PAD; [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] one paper had a sample size of only 39 patients; 45 and three were review articles. [46] [47] [48] Figure 1 shows the study selection process. Table 1 provides the overall characteristics of 22 excluded articles (not including the three review articles).
Eight studies meeting the inclusion criteria reported on a total of 2043 patients (or limbs): some studies used the number of patients as variables for identification of significant stenosis, whereas others used the number of limbs. Table 2 presents characteristics of the studies selected. Of these, all (100%) underwent a reference test except in one study, 23 where angiograms were available for 53 of these patients. There were some differences in ABI methodology in eight papers.
Because PAD is associated with age, smoking status, type 2 diabetes, hypertension, and dyslipidemia, baseline measures of these variables are obtained through corresponding authors. Table 3 presents baseline demographic characteristics of these patients. A total of 786 limbs were from women and 807 limbs were from men. Age was reported in the studies and ranged from 35 to 94 years old. Table 4 provides detailed data on positive, negative, sensitivity, specificity, accuracy and other selected characteristics. Sensitivity ranged from 15.0% to 79.0%, whereas specificity and accuracy ranged from 83.3% to 99.0% and 72.1% to 89.2%, respectively.
Discussion
The present study represents the first structured review focusing on ABI for the diagnosis of PAD, and indicates that an ABI ≤ 0.90 has a perfect specificity and high accuracy, but its sensitivity varied widely and is lower than the approximately 90% sensitivity reported in previous articles. 7, 28, [49] [50] [51] Furthermore, many imperfect diagnostic methods were found in the studies when compared with the ABI test as standard references, and different methods have existed for ABI calculation in the literature. In addition, eight studies differed in international scope, populations, design, and clinical settings.
According to recent guidelines for the Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), the ABI should be considered for patients with PAD who have adverse prognostic features. Both the American Heart Association and American Diabetes Association recommend annual screening for lower extremity arterial disease (LEAD) in patients with type 2 diabetes and those aged over 40 years old. 52 We also found that the test of ABI ≤ 0.90 has an excellent specificity (83.3-99.0%) and high accuracy (72.1-89.2%) in these studies.
However, the sensitivity of the ABI test varied widely among these published studies.
ABI detection in type 2 diabetes and the elderly yielded lower sensitivity, 15-20%, 19 63%, 20 68%, 16 69.3% 17 and 70.6%, 22 suggesting that the test may be affected by diabetes status and aging. Many elements may contribute to the sensitivity of ABI detection, including patients' age, ethnicity, and health status, as well as other factors. Our review includes patients with a wide age range (35-94 years old), and thus arterial wall calcinosis in elderly individuals might have led to overestimation of artery pressure. Additionally, both genetic and environmental factors may lead to a lower ABI and greater prevalence of PAD in African Americans, 53 who had approximately 1.5 times as much aortic surface involvement of fatty streaks as did non-Hispanic white individuals. 54 However, the difference in ABI is trivial in that Aboyans et al. reported an ABI 0.02 difference between citations excluded after initial screening: 223 articles excluded = 25 reason for exclusion:
• two used a stethoscope and an auscultatory method to determine ABI, respectively; • one used an automatic blood pressure device to determine ABI; two used a tissue oxygen saturation and pedal pulse palpation to determine PAD, respectively; • • one determined ABI at exercise; • two used ABI <0.80 and 1.0 for PAD, respectively; • one used ABI <0.90 for the detection of arterial lesions in extremities; • one used ABI >1.3 for PAD;
• one included patients with stenosis >70% in leg arteries; • 10 did not use an appropriate reference standard for PAD; • one paper had a sample size of only 39 patients;
• three were review articles. African Americans and non-Hispanic white individuals. 55 Furthermore, arterial wall calcinosis in diabetes might lead to an overestimation of the lower limb pressure which leads to a low sensitivity. This may be attributable to increased incidence of arterial calcification, which can cause increased vascular rigidity and spuriously elevate the ABI in diabetes and in elderly individuals. Moreover, the reason for elevated ABI values in spite of stenosis could be due to collateral circulation, which maintains blood flow to the lower limb beyond the obstruction. Wikstrom et al. 19 reported a poor sensitivity of 20% (right leg) and 15% (left leg) on the ABI test. We carefully reviewed this study. In addition to arterial wall calcinosis in elderly individuals (average age was 76 years in this study), WBMRA used in this study had a lower spatial resolution which could result in over-and under-grading of stenosis, especially on the smaller caliber vessels of the lower legs. Furthermore, the ABI was calculated for each leg by only posterior tibial artery pressure with the brachial artery pressure, which was measured unilaterally by a mercury sphygmomanometer instead of the Doppler method. Moreover, the study was imperfect because of the interval (range 3-24 months) between the ABI and WBMRA test; the development of stenosis in some cases during this time frame could not be excluded. All these could contribute to a low sensitivity of ABI for stenosis detection in this study.
The previous articles stated that the ABI test had a sensitivity of > 90% and a specificity of > 95% in diagnosing > 50% stenosis of lower limb arteries. We carefully reviewed these studies and found important differences, which include the following: (i) the populations in these studies were composed of surgical patients and young healthy controls, 7, 49, 50 whereas most of patients had cardiovascular risk factors in our review such as being older, smoking, and having diabetes, hypertension and dyslipidemia; (ii) Ouriel et al. 7 used ABI < 0.97 for diagnosis of PAD and failed to describe the diseased limbs included in their analysis; (iii) Yao et al., 49 Criqui et al. 50 and Carter et al. 51 reported that the ABI was a sensitive test for PAD, but did not report any sensitivity or specificity for the ABI and included less than 50% stenosis in their analysis; 49, 50 (iv) Feigelson et al. 30 reported that a combination of ABI ≤ 0.8 and a posterior tibial peak forward flow ≤ 3 cm/s had a sensitivity of 89% and a specificity of 95% in diagnosing PAD.
The ABI is performed by measuring the systolic blood pressure from both brachial arteries and from the dorsal pedal (DP) or posterior tibial (PT) arteries after the patient has been at rest in the supine position for 10 minutes. Optimal recordings are obtained with blood pressure cuffs that are appropriately sized to the patient's lower calf (immediately above the ankle), and systolic pressures are recorded with a handheld Doppler instrument 16, 17, 19, [20] [21] [22] [23] or oscillometric method. 18 Since ankle arterial pressures are normally greater than 90% of the brachial arterial pressure, an ABI ≤ 0.90 has been used in the diagnosis of PAD. 2, 18, 23 Nevertheless, the three most common methods were used to calculate the ABI: HAP-ABI = higher of DP and PT/ higher of the two brachial systolic pressures; LAP-ABI = lower of DP and PT/higher of the two brachial systolic pressures; ABI = mean of DP and PT/mean of both arms. 16, 17, 56 Furthermore, Tables 1, 2 and 4 show that other methods were also used, which led to different sensitivity and specificity, as well as prevalence of PAD. 10 The LAP-ABI method was superior to HAP-ABI in sensitivity within each leg, which studied significant stenosis of limbs instead of patients. 16, 17 The authors confused the lower of the two ipsilateral ankle pressures with the lower of the right and left leg ABIs; the LAP-ABI method was more sensitive (83.7%, 17 89% 16 vs 69.3%, 17 68% 16 ), but with a less specific and positive predictive value than HAP-ABI (64.3% 17 , 93% 16 vs 83.3% 17 , 99% 16 ). An important theme that emerges from these studies is imperfect diagnostic accuracy of these imaging diagnostic techniques such as WBMRA, CDI, DWA and CDU, which preclude a formal meta-analysis. Therefore, blood pressure has been similarly affected by physical and psychological conditions, the Doppler device, setting circumstances, and technicians' experience. All these lead to variance in accuracy of the ABI test.
A true quantitative meta-analysis is not possible because of the variety in study designs, populations and methods of ABI. Moreover, the comparison of a diagnostic test against imperfect standard references may result in underestimation of the test accuracy. Therefore, a limitation of the present review is that it constituted a qualitative analysis and hence could be considered a subjective appraisal. We chose to include a varied selection of studies to provide a perspective as balanced as possible. The studies originated in many different countries and were conducted by different sponsors. More studies are needed of the sensitivity and specificity of an exact ABI test (≤ 0.90) controlling for as many of the variables mentioned above as possible, with a well-designed and properly controlled protocol, especially by comparison with arteriography in general populations, as well as in elderly individuals and in those with diabetes. Nevertheless, we believe that some important and consistent messages have emerged that should influence the use of ABI in the future.
In conclusion, high specificity and accuracy were reported in these articles indicating that ABI ≤ 0.90 could reliably identify patients with serious stenosis ≥ 50%. Our findings suggest that in populations aged between 40 and 75 years old with at least one vascular risk factor (i.e. hypertension, diabetes, dyslipidemia, tobacco), the ABI should be used for a preliminary diagnosis of PAD because of its simplicity, convenience, high specificity and high degree of accuracy in clinical practice.
